Launched during the Mayo Clinic Platform Accelerate program, backed by Sequoia and Google, and an official Content Partner of the New England Journal of Medicine and The Journal of the American Medical Association OpenEvidence is the world’s leading medical information platform.
我們正在追蹤 OpenEvidence 的市場擴張
OpenEvidence 的國際擴張與競爭對手的比較
OpenEvidence你長條顯示所比較各公司之間的相對規模。
欄位5| 公司 | 市場 | 新市場 | 動能 | 活動 | 擴張評分 |
|---|---|---|---|---|---|
 OpenEvidence你 | 0 | 0 | — | 0 | 0 |
目前並無招聘
註冊以追蹤此公司，並在發生變化時第一時間獲得提醒。
OpenEvidence at ASCO 2026
已結束
Physicians vote with their feet. OpenEvidence is the most trusted Medical AI among U.S. physicians.
進行中
NBC News: "Almost two-thirds of physicians in the U.S. actively use OpenEvidence, across 27 million clinical encounters last month." "Dr. Eric Rubin, the editor-in-chief of The New England Journal of Medicine, said the relationship between his journal and OpenEvidence was 'deeply symbiotic and a win for patients.'" "Dr. Paul Sax, an infectious disease specialist at Boston’s Brigham and Women’s Hospital, said OpenEvidence often “borders on miraculous,” with its AI-supported search providing custo ...
進行中HLTH 2025展示了醫療保健領域的人工智能進展，包括實際證據整合、主動放射學、MRI模型和臨床決策支持。
AI收入集中於少數公司如OpenAI和Anthropic。初創公司超越訂閱模式，探索廣告模式以實現增長。
Corti推出初創加速計劃,為醫療AI創辦人提供高達5,000美元信用額度及監管支援,協助應對60萬歐元合規障礙,其Symphony模型在醫療基準測試中超越OpenAI。
解鎖已驗證電郵與直撥電話
免費 · 無需信用卡
關於 OpenEvidence 業務、市場及增長訊號的快速解答。
